NCK1 Activators
The chemical class referred to as NCK1 Activators encompasses a range of compounds that can modulate the activity of the NCK1 protein within cellular signaling networks. These activators operate through diverse mechanisms, directly or indirectly influencing the activation state of NCK1. For instance, phorbol esters like PMA and TPA activate NCK1 through the activation of Protein Kinase C (PKC), which, in turn, phosphorylates and activates NCK1. Conversely, Dasatinib, a tyrosine kinase inhibitor, can suppress the activity of Src Family Kinases (SFKs), upstream activators of NCK1. By inhibiting SFKs, Dasatinib reduces the phosphorylation and activation of NCK1.
In addition to these direct activators, compounds like Calyculin A and LPA can indirectly enhance NCK1 activation. Calyculin A, a potent phosphatase inhibitor, disrupts the dephosphorylation of NCK1, resulting in its sustained phosphorylation and activation. LPA, on the other hand, activates the Rho GTPase pathway, which indirectly influences NCK1 through downstream effectors involved in NCK1 regulation. These various chemicals collectively constitute the class of NCK1 activators, and their distinct mechanisms highlight the intricate network of cellular signaling pathways through which NCK1 activity can be activated.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA activates PKC (Protein Kinase C), which in turn can phosphorylate and activate NCK1 through downstream signaling cascades. | ||||||
Calyculin A | 101932-71-2 | sc-24000 sc-24000A | 10 µg 100 µg | $163.00 $800.00 | 59 | |
Calyculin A is a potent phosphatase inhibitor that can enhance the phosphorylation of NCK1 by preventing its dephosphorylation, leading to increased activation. | ||||||
Lysophosphatidic Acid | 325465-93-8 | sc-201053 sc-201053A | 5 mg 25 mg | $98.00 $341.00 | 50 | |
LPA activates the Rho GTPase pathway, which can indirectly influence NCK1 by modulating downstream effectors involved in NCK1 regulation. | ||||||
Lipopolysaccharide, E. coli O55:B5 | 93572-42-0 | sc-221855 sc-221855A sc-221855B sc-221855C | 10 mg 25 mg 100 mg 500 mg | $98.00 $171.00 $425.00 $1560.00 | 12 | |
LPS can activate the NF-κB pathway, which may indirectly modulate NCK1 expression and activity through transcriptional regulation. | ||||||
Etoposide (VP-16) | 33419-42-0 | sc-3512B sc-3512 sc-3512A | 10 mg 100 mg 500 mg | $51.00 $231.00 $523.00 | 63 | |
Etoposide induces DNA damage and activates stress response pathways, potentially leading to NCK1 activation as part of the cellular stress response. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin activates adenylyl cyclase, leading to increased cAMP levels, which can influence NCK1 indirectly through cAMP-mediated signaling pathways. | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
Retinoic acid can influence gene expression and may regulate NCK1 levels indirectly through transcriptional control of NCK1 gene expression. | ||||||